Cadrenal Therapeutics raises ~$2.2M in registered direct offering and private placement of shares and warrants

Cadrenal Therapeutics, Inc.

Gross proceeds of ~$2.2M from sale of 207,374 shares at $10.85 per share and warrants to purchase 414,748 shares.
Warrants immediately exercisable at $10.60/share, expire 2 years after effective date of resale registration statement.
Officers and directors subject to 10-day lock-up; company restricted from equity issuance for 10 days and variable rate transactions for one year.
Placement agent H.C. Wainwright receives 7% cash fee and 13,479 placement agent warrants at $13.5625/share.
Closing expected on or about December 16, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.